Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
21.52
+0.13 (0.61%)
Nov 20, 2026, 9:45 AM EST - Market open
Amneal Pharmaceuticals Employees
Amneal Pharmaceuticals had 8,700 employees as of December 31, 2025. The number of employees increased by 400 or 4.82% compared to the previous year. That makes Amneal Pharmaceuticals the 3,754th largest employer in the world and 835th in the United States.
Employees
8,700
Change (1Y)
400
Growth (1Y)
4.82%
Revenue / Employee
$367,324
Profits / Employee
$15,322
Market Cap
7.50B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 8,700 | 400 | 4.82% |
| Dec 31, 2024 | 8,300 | 450 | 5.73% |
| Dec 31, 2023 | 7,850 | 250 | 3.29% |
| Dec 31, 2022 | 7,600 | 600 | 8.57% |
| Dec 31, 2021 | 7,000 | 1,000 | 16.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Dr. Reddy's Laboratories | 27,527 |
| Bausch Health Companies | 20,300 |
| Elanco Animal Health | 9,900 |
| Neurocrine Biosciences | 2,500 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| Lantheus Holdings | 1,193 |
| Supernus | 838 |
AMRX News
- 2 days ago - Amneal Pharmaceuticals granted marketing authorization for Adcomfo by EC - TheFly
- 2 days ago - Amneal Announces European Approval of Adcomfo® (Omalizumab), a Biosimilar to XOLAIR® - GlobeNewsWire
- 9 days ago - Amneal Named BioSpace 2027 Best Place to Work, Ranking No.1 Among Large Employers - GlobeNewsWire
- 14 days ago - Amneal Pharmaceuticals price target raised to $28 from $25 at UBS - TheFly
- 16 days ago - Amneal Pharmaceuticals price target raised to $25 from $24 at JPMorgan - TheFly
- 17 days ago - Amneal Pharmaceuticals Earnings Call Transcript: Q3 2026 - Transcripts
- 17 days ago - Amneal Pharmaceuticals Slides: Q3 2026 - Filings
- 17 days ago - Amneal Pharmaceuticals Earnings release: Q3 2026 - Filings